Alopecia Research Update July to September 2024

Alopecia Research Update: July to September 2024

Written By: Adam Best

Reviewed by: Ramin Eshtiagi, MD.

Published November 7th, 2024

If you’re wondering what the latest research reveals about alopecia, you’re in the right place.

We’ve summarized the newest findings into two key areas:

New alopecia research insights
New alopecia treatment insights

This article covers recent studies on:

A natural sugar with the potential to reverse hair loss
Probiotics for hair loss related to alopecia
Research funding for alopecia in individuals with Down syndrome

Scientists Discover a Natural Sugar That May Reverse Hair Loss Without Side Effects

In a promising development, scientists have discovered that supplementing with 2-deoxy-D-ribose (2dDR), a natural sugar, could potentially reverse hair loss. Initial studies suggest that 2dDR may have effects comparable to Rogaine (Minoxidil). Although research is still in its early stages, tests in mice showed that those given 2dDR experienced hair regrowth similar to that achieved with Rogaine. This breakthrough could lead to clinical trials, and if successful, 2dDR might offer a side-effect-free alternative to Rogaine.

Link to study here

Probiotic Blend Reduces Hair Loss in Androgenitic Alopecia

A recent study published in Nutrients explored the effects of a probiotic blend on androgenetic alopecia (AGA) by targeting the gut-skin axis. Conducted by Darwin Bioprospecting Excellence, this trial involved 136 participants over 16 weeks, using a mix of Lactiplantibacillus strains. Results showed that those who took the probiotic blend experienced a significant reduction in hair shedding and increased hair growth compared to the placebo group.

Researchers hypothesize that probiotics may support hair health by balancing the gut microbiome, which can improve biotin levels—a key nutrient for hair and skin. This probiotic approach could serve as a natural complement to existing treatments like Minoxidil and Finasteride, emphasizing the role of the gut-skin axis in treating skin and hair conditions.

Link to study here

Mount Sinai Secures Over $4 Million Grant From National Institutes of Health to Study Alopecia Areata and Atopic Dermatitis in People With Down Syndrome

The National Institutes of Health (NIH) has awarded Mount Sinai over $4 million to study alopecia areata and atopic dermatitis in individuals with Down syndrome. Research shows that people with Down syndrome have a higher prevalence of dermatological issues, often tied to immune system abnormalities and skin sensitivities.

This grant will support research into personalized therapies that consider the unique needs of people with Down syndrome, potentially leading to more effective and targeted treatments for these skin conditions.

Link to study here

Additional Resources

Looking for more updates? Check out our post on new alopecia drug developments from July to September 2024 [here].

Join a Clinical Trial for alopecia areata in Barrie

We’re currently recruiting patients for alopecia areata (A.A.) clinical trials. If your A.A. has resisted standard treatments, you may be eligible to participate in a study evaluating a potential new therapy. This could be an opportunity to find an effective treatment and contribute to developing better options for others with A.A.

View our clinical trials here.

SimcoDerm is a full service, comprehensive dermatology clinic located in Barrie. We provide our services to all the patients in Simcoe County and beyond.

Contact